Announcements


FDA/CDER-BARDA Innovations in Medical Countermeasure Continuous Manufacturing Request for Information

Advanced Development of More Effective/Universal Influenza Vaccines Request for Proposals (RFP)

New initiative supporting the advanced development of influenza vaccine candidates with the goal to provide enhanced, long-lasting protection from a broad range of antigenically divergent influenza viruses within and across subtypes.

more announcements

Conferences

Recent Publications

PHEMCE Strategy and Implementation Plan 2014

The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan (SIP) describes the priorities that HHS, in collaboration with its interagency partners, will implement over the next five years.

Project BioShield Annual Report 2013

The Project BioShield Act of 2004 [Project BioShield (PBS); Public Law [P.L.] 108-276] amended the Public Health Service (PHS) Act and the Federal Food, Drug, and Cosmetic (FD&C) Act to provide additional and more flexible authorities and funding to support financially the development and procurement of medical countermeasures....

Project BioShield Annual Report to Congress 2012

The Medical Countermeasures (MCM) Enterprise had a significant year in 2012. The U.S. Department of Health and Human Services’ (HHS) continued to leverage recommendations of the “Public Health Emergency Medical Countermeasures Enterprise Review...

PHEMCE Implementation Plan 2012

The 2012 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan describes the priorities that HHS, in collaboration with its interagency partners, will implement over the next five years to advance ...

PHEMCE Strategy 2012

The U.S. Government has a responsibility to protect the health and safety of its citizens. The American people continue to face a host of national health security threats from chemical, biological, radiological, and nuclear (CBRN) agents...

view all publications